Commentary on Sawangjit et al. (2017)

there is still much to be determined before policy makers can choose pharmacy needle and syringe programmes (NSP) confidently over other models of NSP provision

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)248-249
Number of pages2
JournalAddiction
Volume112
Issue number2
DOIs
Publication statusPublished - 1 Feb 2017

Keywords

  • Blood borne viruses
  • coverage
  • injecting risk
  • needle and syringe programme
  • opiate substitution theraphy
  • pharmacy

Cite this

@article{9b783b20cf71402fb3376df6ddb4264e,
title = "Commentary on Sawangjit et al. (2017): there is still much to be determined before policy makers can choose pharmacy needle and syringe programmes (NSP) confidently over other models of NSP provision",
keywords = "Blood borne viruses, coverage, injecting risk, needle and syringe programme, opiate substitution theraphy, pharmacy",
author = "Jenny Scott",
year = "2017",
month = "2",
day = "1",
doi = "10.1111/add.13647",
language = "English",
volume = "112",
pages = "248--249",
journal = "Addiction",
issn = "0965-2140",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Commentary on Sawangjit et al. (2017)

T2 - there is still much to be determined before policy makers can choose pharmacy needle and syringe programmes (NSP) confidently over other models of NSP provision

AU - Scott, Jenny

PY - 2017/2/1

Y1 - 2017/2/1

KW - Blood borne viruses

KW - coverage

KW - injecting risk

KW - needle and syringe programme

KW - opiate substitution theraphy

KW - pharmacy

UR - http://www.scopus.com/inward/record.url?scp=85008975678&partnerID=8YFLogxK

UR - http://dx.doi.org/10.1111/add.13647

U2 - 10.1111/add.13647

DO - 10.1111/add.13647

M3 - Comment/debate

VL - 112

SP - 248

EP - 249

JO - Addiction

JF - Addiction

SN - 0965-2140

IS - 2

ER -